PTCHFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as PRTCY

PureTech Health plc

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026

$1.48+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

PureTech Health plc balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Cash & Equivalents	252	281	191	150	466	404	132	117	73
Cash & Short-Term Investments	252	281	191	150	466	404	132	117	73
Receivables	1.76	1.52	2.38	12	3.17	2.56	1.98	–	–
Total Current Assets	305	386	347	386	502	414	169	–	–
Property, Plant & Equipment	5.20	7.07	9.54	23	27	23	21	–	–
Operating Lease Right-of-Use Assets	6.30	8.06	9.83	14	17	20	22	10	–
Intangible Assets	–	–	0.91	0.83	0.99	0.90	0.63	–	–
Deferred Tax Assets	–	–	0	–	–	0	0.14	–	–
Other Long-Term Assets	0.17	0.48	0.88	0.01	0.81	0.01	0.10	–	–
Total Assets	535	603	694	703	946	990	941	–	–
Accounts Payable	23	27	44	55	36	22	20	–	–
Current Portion of Long-Term Debt	–	–	0	5.16	0.86	0	–	–	–
Current Debt	–	–	0	5.16	0.86	0	–	–	–
Current Portion of Leases	3.58	3.58	3.39	4.97	3.95	3.26	2.93	–	–
Current Income Taxes Payable	1.21	0.08	0	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	0.73	0.73	0.52	–	–
Total Current Liabilities	46	41	51	97	226	181	139	–	–
Long-Term Debt	–	–	0	10	14	15	0	–	–
Long-Term Leases	11	15	18	24	29	32	35	–	–
Operating Lease Liabilities	15	18	22	29	33	35	38	11	–
Deferred Tax Liabilities	–	0	52	20	90	109	115	–	–
Total Liabilities	229	195	236	155	362	336	291	–	–
Total Debt	–	–	0	15	15	15	0	–	–
Common Stock	4.86	4.86	5.46	5.46	5.44	5.42	5.41	–	–
Additional Paid-In Capital	290	290	290	290	289	289	288	–	–
Retained Earnings	-77	32	84	150	200	260	254	–	–
Treasury Stock	-41	-47	-45	-26	0	–	–	–	–
Shareholders' Equity	312	415	464	542	594	670	668	–	–
Noncontrolling Interest	-6.40	-6.77	-5.84	5.37	-9.37	-16	-18	–	–
Total Equity	306	408	458	548	584	654	650	168	72
Total Liabilities & Equity	535	603	694	703	946	990	941	–	–
Shares Outstanding(shares)	–	239	272	279	288	286	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: –
Operating margin: -2114.8%
Net margin: -2355.4%
Return on equity, FY2025: -30.2%

Financial strength

Current ratio: 6.59
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 545.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –